A recent study, incorporating both in vitro and in vivo experiments, reported that the CDK1-SRC interaction-driven transcriptional activation of HSP90AB1 enhances antitumor immunity in HCC [34]. This evidence concerns the gene SRC and hepatocellular carcinoma.